Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.

Weiskirchen R.

Front Pharmacol. 2019 Oct 25;10:1289. doi: 10.3389/fphar.2019.01289. eCollection 2019. No abstract available.

2.

Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.

Pinheiro D, Dias I, Ribeiro Silva K, Stumbo AC, Thole A, Cortez E, de Carvalho L, Weiskirchen R, Carvalho S.

Cells. 2019 Oct 29;8(11). pii: E1339. doi: 10.3390/cells8111339. Review.

3.

Magnetic-Assisted Treatment of Liver Fibrosis.

Levada K, Omelyanchik A, Rodionova V, Weiskirchen R, Bartneck M.

Cells. 2019 Oct 19;8(10). pii: E1279. doi: 10.3390/cells8101279. Review.

4.

Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.

Evliyaoglu O, van Helden J, Jaruschewski S, Imöhl M, Weiskirchen R.

Clin Biochem. 2019 Sep 14. pii: S0009-9120(19)30545-4. doi: 10.1016/j.clinbiochem.2019.09.004. [Epub ahead of print]

PMID:
31526775
5.

Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on N-Glycosylation.

Meurer S, Wimmer AE, Leur EV, Weiskirchen R.

Cells. 2019 Aug 28;8(9). pii: E997. doi: 10.3390/cells8090997.

6.

High Prevalence of Sticky Platelet Syndrome in Patients with Infertility and Pregnancy Loss.

Yagmur E, Bast E, Mühlfeld AS, Koch A, Weiskirchen R, Tacke F, Neulen J.

J Clin Med. 2019 Aug 28;8(9). pii: E1328. doi: 10.3390/jcm8091328.

7.

Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1.

Stremmel W, Staffer S, Weiskirchen R.

Int J Mol Sci. 2019 Aug 19;20(16). pii: E4034. doi: 10.3390/ijms20164034.

8.

Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer.

Fiegle E, Doleschel D, Koletnik S, Rix A, Weiskirchen R, Borkham-Kamphorst E, Kiessling F, Lederle W.

Neoplasia. 2019 Sep;21(9):932-944. doi: 10.1016/j.neo.2019.07.006. Epub 2019 Aug 11.

9.

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Drescher HK, Weiskirchen S, Weiskirchen R.

Cells. 2019 Aug 7;8(8). pii: E845. doi: 10.3390/cells8080845. Review.

10.

The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH).

Drescher HK, Weiskirchen R, Fülöp A, Hopf C, de San Román EG, Huesgen PF, de Bruin A, Bongiovanni L, Christ A, Tolba R, Trautwein C, Kroy DC.

Front Physiol. 2019 Jun 25;10:770. doi: 10.3389/fphys.2019.00770. eCollection 2019.

11.

Decreased CTRP3 Plasma Concentrations Are Associated with Sepsis and Predict Mortality in Critically Ill Patients.

Yagmur E, Otto S, Koek GH, Weiskirchen R, Trautwein C, Koch A, Tacke F.

Diagnostics (Basel). 2019 Jun 21;9(2). pii: E63. doi: 10.3390/diagnostics9020063.

12.

The interesting case-orphan diseases-double trouble.

Reuner U, Stremmel W, Weiskirchen R.

Ann Transl Med. 2019 Apr;7(Suppl 2):S74. doi: 10.21037/atm.2019.04.31.

13.

Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry.

Weiskirchen S, Kim P, Weiskirchen R.

Ann Transl Med. 2019 Apr;7(Suppl 2):S72. doi: 10.21037/atm.2018.10.67. Review.

14.

Clinical features of Wilson disease.

Stremmel W, Merle U, Weiskirchen R.

Ann Transl Med. 2019 Apr;7(Suppl 2):S61. doi: 10.21037/atm.2019.01.20. Review.

15.

Editorial for focused issue "Wilson Disease: From Genetics to Management of Disease".

Weiskirchen R, Stremmel W.

Ann Transl Med. 2019 Apr;7(Suppl 2):S55. doi: 10.21037/atm.2018.12.06. No abstract available.

16.

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis.

Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F.

Cells. 2019 May 24;8(5). pii: E503. doi: 10.3390/cells8050503.

17.

Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro.

Mahli A, Seitz T, Beckröge T, Freese K, Thasler WE, Benkert M, Dietrich P, Weiskirchen R, Bosserhoff A, Hellerbrand C.

Cells. 2019 May 15;8(5). pii: E457. doi: 10.3390/cells8050457.

18.

Elevated CTRP1 Plasma Concentration Is Associated with Sepsis and Pre-Existing Type 2 Diabetes Mellitus in Critically Ill Patients.

Yagmur E, Buergerhausen D, Koek GH, Weiskirchen R, Trautwein C, Koch A, Tacke F.

J Clin Med. 2019 May 11;8(5). pii: E661. doi: 10.3390/jcm8050661.

19.

The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats.

Iwasaki J, Afify M, Bleilevens C, Klinge U, Weiskirchen R, Steitz J, Vogt M, Yagi S, Nagai K, Uemoto S, Tolba RH.

Int J Mol Sci. 2019 Apr 29;20(9). pii: E2114. doi: 10.3390/ijms20092114.

20.

Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease.

Mahli A, Seitz T, Freese K, Frank J, Weiskirchen R, Abdel-Tawab M, Behnam D, Hellerbrand C.

Cells. 2019 Apr 17;8(4). pii: E359. doi: 10.3390/cells8040359.

21.

Platelet Factor 4 Attenuates Experimental Acute Liver Injury in Mice.

Drescher HK, Brandt EF, Fischer P, Dreschers S, Schwendener RA, Kowalska MA, Canbay A, Wasmuth HE, Weiskirchen R, Trautwein C, Berres ML, Kroy DC, Sahin H.

Front Physiol. 2019 Mar 26;10:326. doi: 10.3389/fphys.2019.00326. eCollection 2019.

22.

The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis.

Hansel C, Erschfeld S, Baues M, Lammers T, Weiskirchen R, Trautwein C, Kroy DC, Drescher HK.

Front Pharmacol. 2019 Mar 13;10:244. doi: 10.3389/fphar.2019.00244. eCollection 2019.

23.

Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis.

Sun Q, Baues M, Klinkhammer BM, Ehling J, Djudjaj S, Drude NI, Daniel C, Amann K, Kramann R, Kim H, Saez-Rodriguez J, Weiskirchen R, Onthank DC, Botnar RM, Kiessling F, Floege J, Lammers T, Boor P.

Sci Transl Med. 2019 Apr 3;11(486). pii: eaat4865. doi: 10.1126/scitranslmed.aat4865.

PMID:
30944168
24.

Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma.

Asimakopoulou A, Vucur M, Luedde T, Schneiders S, Kalampoka S, Weiss TS, Weiskirchen R.

Cancers (Basel). 2019 Mar 19;11(3). pii: E385. doi: 10.3390/cancers11030385.

25.

Hypoxia Induces Astrocyte-Derived Lipocalin-2 in Ischemic Stroke.

Ranjbar Taklimie F, Gasterich N, Scheld M, Weiskirchen R, Beyer C, Clarner T, Zendedel A.

Int J Mol Sci. 2019 Mar 13;20(6). pii: E1271. doi: 10.3390/ijms20061271.

26.

Has GnRH a direct role in AMH regulation?

van Helden J, Evliyaoglu O, Weiskirchen R.

Clin Endocrinol (Oxf). 2019 Jun;90(6):827-833. doi: 10.1111/cen.13967. Epub 2019 Apr 16.

PMID:
30868616
27.

Structure of mammalian plasma fetuin-B and its mechanism of selective metallopeptidase inhibition.

Cuppari A, Körschgen H, Fahrenkamp D, Schmitz C, Guevara T, Karmilin K, Kuske M, Olf M, Dietzel E, Yiallouros I, de Sanctis D, Goulas T, Weiskirchen R, Jahnen-Dechent W, Floehr J, Stoecker W, Jovine L, Gomis-Rüth FX.

IUCrJ. 2019 Feb 28;6(Pt 2):317-330. doi: 10.1107/S2052252519001568. eCollection 2019 Mar 1.

28.

Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.

van Roeyen CRC, Martin IV, Drescher A, Schuett KA, Hermert D, Raffetseder U, Otten S, Buhl EM, Braun GS, Kuppe C, Liehn E, Boor P, Weiskirchen R, Eriksson U, Gross O, Eitner F, Floege J, Ostendorf T.

Kidney Int. 2019 May;95(5):1103-1119. doi: 10.1016/j.kint.2018.11.031. Epub 2019 Feb 28.

PMID:
30827511
29.

Software solutions for evaluation and visualization of laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI) data: a short overview.

Weiskirchen R, Weiskirchen S, Kim P, Winkler R.

J Cheminform. 2019 Feb 18;11(1):16. doi: 10.1186/s13321-019-0338-7. Review.

30.

Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases.

Karmilin K, Schmitz C, Kuske M, Körschgen H, Olf M, Meyer K, Hildebrand A, Felten M, Fridrich S, Yiallouros I, Becker-Pauly C, Weiskirchen R, Jahnen-Dechent W, Floehr J, Stöcker W.

Sci Rep. 2019 Jan 24;9(1):546. doi: 10.1038/s41598-018-37024-5.

31.

Liver parenchymal cells lacking Lipocalin 2 (LCN2) are prone to endoplasmic reticulum stress and unfolded protein response.

Borkham-Kamphorst E, Van de Leur E, Haas U, Weiskirchen R.

Cell Signal. 2019 Mar;55:90-99. doi: 10.1016/j.cellsig.2019.01.001. Epub 2019 Jan 4.

PMID:
30615971
32.

Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease.

Weiskirchen R, Tacke F.

Cells. 2019 Jan 1;8(1). pii: E16. doi: 10.3390/cells8010016. Review.

33.

Vitamin B1 interpretation: Erroneous higher levels in non-anemic populations.

Evliyaoglu O, van Helden J, Imöhl M, Weiskirchen R.

Nutrition. 2019 Apr;60:25-29. doi: 10.1016/j.nut.2018.09.002. Epub 2018 Sep 5.

PMID:
30529183
34.

Quantification of liver iron overload disease with laser ablation inductively coupled plasma mass spectrometry.

Kim P, Weiskirchen S, Uerlings R, Kueppers A, Stellmacher F, Viveiros A, Zoller H, Weiskirchen R.

BMC Med Imaging. 2018 Dec 4;18(1):51. doi: 10.1186/s12880-018-0291-3.

35.

Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.

Hassan R, Tammam SN, Safy SE, Abdel-Halim M, Asimakopoulou A, Weiskirchen R, Mansour S.

Eur J Pharm Biopharm. 2019 Jan;134:96-106. doi: 10.1016/j.ejpb.2018.11.018. Epub 2018 Nov 22.

PMID:
30471341
36.

Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23).

van Helden J, Weiskirchen R.

Scand J Clin Lab Invest. 2018 Nov - Dec;78(7-8):584-590. doi: 10.1080/00365513.2018.1526411. Epub 2018 Oct 31.

PMID:
30380963
37.

An update on the recent advances in antifibrotic therapy.

Tacke F, Weiskirchen R.

Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1143-1152. doi: 10.1080/17474124.2018.1530110. Epub 2018 Oct 3. Review.

PMID:
30261763
38.

Cross-method comparison of serum androstenedione measurement with respect to the validation of a new fully automated chemiluminescence immunoassay.

van Helden J, Weiskirchen R.

Clin Biochem. 2018 Dec;62:32-38. doi: 10.1016/j.clinbiochem.2018.09.009. Epub 2018 Sep 24.

PMID:
30261182
39.

Visfatin Serum Levels Predict Mortality in Critically Ill Patients.

Koch A, Weiskirchen R, Krusch A, Bruensing J, Buendgens L, Herbers U, Yagmur E, Koek GH, Trautwein C, Tacke F.

Dis Markers. 2018 Aug 26;2018:7315356. doi: 10.1155/2018/7315356. eCollection 2018.

40.

Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.

Sonntag R, Giebeler N, Nevzorova YA, Bangen JM, Fahrenkamp D, Lambertz D, Haas U, Hu W, Gassler N, Cubero FJ, Müller-Newen G, Abdallah AT, Weiskirchen R, Ticconi F, Costa IG, Barbacid M, Trautwein C, Liedtke C.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9282-9287. doi: 10.1073/pnas.1807155115. Epub 2018 Aug 27.

41.

Mining the Age-Dependent Reference Intervals of B Vitamins from Routine Laboratory Test Results.

Evliyaoglu O, van Helden J, Imöhl M, Weiskirchen R.

Lab Med. 2019 Jan 1;50(1):54-63. doi: 10.1093/labmed/lmy045.

PMID:
30085194
42.

High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients.

Koch A, Yagmur E, Linka J, Schumacher F, Bruensing J, Buendgens L, Herbers U, Koek GH, Weiskirchen R, Trautwein C, Tacke F.

Dis Markers. 2018 Jul 8;2018:8583121. doi: 10.1155/2018/8583121. eCollection 2018.

43.

Schistosoma mansoni Egg-Secreted Antigens Activate Hepatocellular Carcinoma-Associated Transcription Factors c-Jun and STAT3 in Hamster and Human Hepatocytes.

Roderfeld M, Padem S, Lichtenberger J, Quack T, Weiskirchen R, Longerich T, Schramm G, Churin Y, Irungbam K, Tschuschner A, Windhorst A, Grevelding CG, Roeb E.

Hepatology. 2018 Jul 27. doi: 10.1002/hep.30192. [Epub ahead of print]

PMID:
30053321
44.

Portal myofibroblasts are sensitive to CCN-mediated endoplasmic reticulum stress-related apoptosis with potential to attenuate biliary fibrogenesis.

Borkham-Kamphorst E, Steffen BT, van de Leur E, Haas U, Weiskirchen R.

Cell Signal. 2018 Nov;51:72-85. doi: 10.1016/j.cellsig.2018.07.005. Epub 2018 Jul 22.

PMID:
30044965
45.

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts.

Weiskirchen R, Weiskirchen S, Tacke F.

F1000Res. 2018 Jun 27;7. pii: F1000 Faculty Rev-921. doi: 10.12688/f1000research.14841.1. eCollection 2018. Review.

46.

Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients.

Koch A, Yagmur E, Hoss A, Buendgens L, Herbers U, Weiskirchen R, Koek GH, Trautwein C, Tacke F.

J Clin Lab Anal. 2018 Nov;32(9):e22614. doi: 10.1002/jcla.22614. Epub 2018 Jul 5.

PMID:
29974524
47.

Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications.

Weiskirchen R, Weiskirchen S, Tacke F.

Mol Aspects Med. 2019 Feb;65:2-15. doi: 10.1016/j.mam.2018.06.003. Epub 2018 Jun 30. Review.

PMID:
29958900
48.

High mobility group box 1 as a biomarker in critically ill patients.

Yagmur E, Buendgens L, Herbers U, Beeretz A, Weiskirchen R, Koek GH, Trautwein C, Tacke F, Koch A.

J Clin Lab Anal. 2018 Oct;32(8):e22584. doi: 10.1002/jcla.22584. Epub 2018 Jun 3.

PMID:
29862569
49.

Brain copper storage after genetic long-term correction in a mouse model of Wilson disease.

Uerlings R, Moreno D, Murillo O, Gazquez C, Hernández-Alcoceba R, González-Aseguinolaza G, Weiskirchen R.

Neurol Genet. 2018 May 18;4(3):e243. doi: 10.1212/NXG.0000000000000243. eCollection 2018 Jun. No abstract available.

50.

N-Glycosylation of Lipocalin 2 Is Not Required for Secretion or Exosome Targeting.

Borkham-Kamphorst E, Van de Leur E, Meurer SK, Buhl EM, Weiskirchen R.

Front Pharmacol. 2018 Apr 25;9:426. doi: 10.3389/fphar.2018.00426. eCollection 2018.

Supplemental Content

Loading ...
Support Center